GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Sipai Health Technology Co Ltd (FRA:AX1) » Definitions » 14-Day RSI

Sipai Health Technology Co (FRA:AX1) 14-Day RSI : 56.06 (As of May. 05, 2024)


View and export this data going back to 2023. Start your Free Trial

What is Sipai Health Technology Co 14-Day RSI?

The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30.

As of today (2024-05-05), Sipai Health Technology Co's 14-Day RSI is 56.06.

The industry rank for Sipai Health Technology Co's 14-Day RSI or its related term are showing as below:

FRA:AX1's 14-Day RSI is ranked worse than
71.43% of 105 companies
in the Medical Distribution industry
Industry Median: 51.31 vs FRA:AX1: 56.06

Competitive Comparison of Sipai Health Technology Co's 14-Day RSI

For the Medical Distribution subindustry, Sipai Health Technology Co's 14-Day RSI, along with its competitors' market caps and 14-Day RSI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sipai Health Technology Co's 14-Day RSI Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Sipai Health Technology Co's 14-Day RSI distribution charts can be found below:

* The bar in red indicates where Sipai Health Technology Co's 14-Day RSI falls into.



Sipai Health Technology Co  (FRA:AX1) 14-Day RSI Calculation

The formula for calculating RSI is:

RSI=100[ 100 / ( 1 + Average Gain / Average Loss )]

* Note that the formula uses a positive value for the average loss.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sipai Health Technology Co  (FRA:AX1) 14-Day RSI Explanation

The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.

Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.

RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections.


Sipai Health Technology Co 14-Day RSI Related Terms

Thank you for viewing the detailed overview of Sipai Health Technology Co's 14-Day RSI provided by GuruFocus.com. Please click on the following links to see related term pages.


Sipai Health Technology Co (FRA:AX1) Business Description

Traded in Other Exchanges
Address
No. 1888, Caoyang Road, 7/F, Building 3, Xingguangyao Plaza, Putuo District, Shanghai, CHN
Sipai Health Technology Co Ltd is a medical technology and health management company in China. It has three reportable operating segments: Specialty Pharmacy Business - operation and distribution of specialty pharmacy stores and pharmaceutical products; Physician Research Assistance Business - offering pharmaceutical companies and other clinical trial institutions site management organization services; Health Insurance Services Business - rendering insurance brokerage services to insurance companies. The company generates key revenue from Specialty Pharmacy Business. Almost all of the company's revenues were derived from operations in the PRC.

Sipai Health Technology Co (FRA:AX1) Headlines

No Headlines